Delivery Order SPE2DR25D1017-SPE2DR26F9DWW
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,078.93 on January 20, 2026, to supply Jardiance 25 mg tablets (90-count) to the Defense Logistics Agency with an ultimate completion date of January 21, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,790.55 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on January 27, 2026, with an ultimate completion date of January 28, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award to the vendor. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters....
- The Defense Logistics Agency awarded a $105,814.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) with an ultimate completion date of January 23, 2026. This contract was awarded on a non-set-aside, competitive basis to the Conshohocken, Pennsylvania-based pharmaceutical distributor, a subsidiary of parent company Cencora, Inc. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $6,274.13 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on January 8, 2026, with an ultimate completion date of January 9, 2026. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award on a full and open basis. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order valued at $17,796.50 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order valued at $11,937.78 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on January 20, 2026, with an ultimate completion date of January 21, 2026. This is a firm fixed-price, non-set-aside contract performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $14,812.86 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed-price contract. The order was competitively awarded without set-aside designation and carries an ultimate completion date of October 20, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $21,473.87 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on January 22, 2026, with completion scheduled for January 23, 2026. This competitive award, structured as a firm fixed-price delivery order with no set-aside designation, represents a task order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is located in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,130.81 on July 31, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price, competitively awarded contract has an ultimate completion date of August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Jardiance 25 mg tablets (90-count) with a ceiling value of $24,362.76 under a firm fixed-price contract structure. The order was competitively awarded with no set-aside designation and carries an ultimate completion date of September 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the contract at its corporate office location. This delivery order is issued against the...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9DWWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,879.86 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on January 28, 2026, with an ultimate completion date of January 29, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under the company's parent organization, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031. The underlying IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. AmerisourceBergen's federal contract portfolio demonstrates its critical role as a major pharmaceutical distributor serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The current delivery order for Jardiance, a diabetes medication, exemplifies the company's ongoing support of military and veteran healthcare needs through the DLA supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 1/27/26 |